drug · antibody
patient view →sarilumab
Phase 2updated 2mo agoby $REGN REGENERON PHARMACEUTICALS, INC.🔗 ChEMBL
Phase 2community read0 votes
Antibody drug with a maximum clinical stage of Approval (across all indications), with an approval for rheumatoid arthritis and immune system disease and 10 investigational indications.
indications
indications
Rheumatoid Arthritis
targets
Interleukin-6 receptor subunit alpha
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that